News › Clinical Practice, Industry News, Patient Care

Sculptra and Restylane Deliver 9-Month Skin, Confidence Boost Post-medication Weight Loss

August 1, 2025

Galderma recently announced final nine-month results from its phase 4 clinical trial confirming that the combination of Sculptra and Restylane Lyft or Contour delivers sustained improvement in facial appearance and high patient satisfaction for individuals facing aesthetic changes due to medication-driven weight loss.

The results, said clinical trial investigator Michael Somenek, MD, represent an evolution in how the aesthetics field can holistically support patients through their weight loss journey, both physically and emotionally.

Read more at Dermatology Times >>

 

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • 2026 Med Spa Industry Survey Now Open to Responses
    • South Carolina Medical Board Warns Against Use of Research-Grade Peptides
    • Lilly Sues Six Companies Over Alleged Sales of Experimental Weight-Loss Drug Retatrutide
    • DaySpark Becomes Silver Vendor Affiliate with the American Med Spa Association
    • Allergan Aesthetics Refreshes Allergan Partner Privileges to Better Support Today’s Modern Aesthetics Practices
Advertisement